“TOCILIZUMAB AS MONOCLONAL ANTIBODY THERAPY IN OVERCOMING ACUTE RESPIRATORY DISTRESS SYNDROME IN COVID-19 PATIENTS”. 2022. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia 9 (3): 92-101. https://doi.org/10.53366/jimki.v9i3.488.